Published by Josh White on 28th January 2022
(Sharecast News) - Cell and gene therapy specialist Oxford Biomedica announced an agreement with Homology Medicines on Friday, as well as a placing to raise £80m from new and existing shareholders, including a retail offer through the PrimaryBid platform.
URL: http://www.digitallook.com/dl/news/story/32424784/...